Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Bourcier, Jessie
15  Ergebnisse:
Personensuche X
?
1

Kinase-impaired BTK mutations are susceptible to clinical-s..:

Montoya, Skye ; Bourcier, Jessie ; Noviski, Mark...
Science.  383 (2024)  6682 - p. , 2024
Link: https://doi.org/10.1126/..
 
?
2

Modulation of RNA splicing enhances response to BCL2 inhibi..:

Wang, Eric ; Pineda, Jose Mario Bello ; Kim, Won Jun...
Cancer Cell.  41 (2023)  1 - p. 164-180.e8 , 2023
Link: https://doi.org/10.1016/..
 
?
3

E7820, an anti-cancer sulfonamide, degrades RBM39 in patien..:

Bewersdorf, Jan Philipp ; Stahl, Maximilian ; Taylor, Justin...
Leukemia.  37 (2023)  12 - p. 2512-2516 , 2023
Link: https://doi.org/10.1038/..
 
?
4

Clinical characteristics and outcomes of relapsed follicula..:

Sesques, Pierre ; Bourcier, Jessie ; Golfier, Camille...
Hematological Oncology.  38 (2020)  2 - p. 137-145 , 2020
Link: https://doi.org/10.1002/..
 
?
5

Fluctuating plasmacytosis in an immunocompetent woman leadi..:

Debord, Camille ; Bourcier, Jessie ; Subiger, François...
Annals of Hematology.  100 (2020)  1 - p. 285-287 , 2020
Link: https://doi.org/10.1007/..
 
?
6

Prevalence of the reversed halo sign in neutropenic patient..:

Bourcier, Jessie ; Heudes, Pierre‐Marie ; Morio, Florent...
Mycoses.  60 (2017)  8 - p. 526-533 , 2017
Link: https://doi.org/10.1111/..
 
?
7

Modulation of RNA splicing enhances response to BCL2 inhibi..:

Wang, Eric ; Pineda, Jose Mario Bello ; Kim, Won Jun...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9839614/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
8

E7820, an anti-cancer sulfonamide, degrades RBM39 in patien..:

Bewersdorf, Jan Philipp ; Stahl, Maximilian ; Taylor, Justin...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10681888/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
9

Splicing-Mediated Antigen Escape from Immunotherapy for B-c..:

Bourcier, Jessie ; Abdel-Wahab, Omar
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9245399/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
10

BH3-mimetic toolkit guides the respective use of BCL2 and M..:

Gomez-Bougie, Patricia ; Maïga, Sophie ; Tessoulin, Benoit...
info:eu-repo/semantics/altIdentifier/doi/10.1182/blood-2018-03-836718.  , 2018
Link: https://www.hal.inserm.f..
 
?
11

BH3-mimetic toolkit guides the respective use of BCL2 and M..:

Gomez-Bougie, Patricia ; Maïga, Sophie ; Tessoulin, Benoit...
info:eu-repo/semantics/altIdentifier/doi/10.1182/blood-2018-03-836718.  , 2018
Link: https://inserm.hal.scien..
 
?
12

BH3-mimetic toolkit guides the respective use of BCL2 and M..:

Gomez-Bougie, Patricia ; Maïga, Sophie ; Tessoulin, Benoit...
info:eu-repo/semantics/altIdentifier/doi/10.1182/blood-2018-03-836718.  , 2018
Link: https://inserm.hal.scien..
 
?
13

BH3-mimetic toolkit guides the respective use of BCL2 and M..:

Gomez-Bougie, Patricia ; Maïga, Sophie ; Tessoulin, Benoit...
info:eu-repo/semantics/altIdentifier/doi/10.1182/blood-2018-03-836718.  , 2018
Link: https://inserm.hal.scien..
 
?
14

BH3-mimetic toolkit guides the respective use of BCL2 and M..:

Gomez-Bougie, Patricia ; Maïga, Sophie ; Tessoulin, Benoit...
info:eu-repo/semantics/altIdentifier/doi/10.1182/blood-2018-03-836718.  , 2018
Link: https://inserm.hal.scien..
 
?
15

Subcutaneous bortezomib incorporated into the bortezomib-th..:

Lok, Anne ; Mocquard, Julie ; Bourcier, Jessie...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3943328.  , 2014
Link: http://www.ncbi.nlm.nih...
 
1-15